Persistent CMV in Brain Tissue of a Patient with Congenital CMV Following Resolution of Viremia
Jeffrey Kuerbitz1, Gail Demmler2, Lisa Emrick1
1Department of Neurology & Developmental Neuroscience, 2Infectious Disease, Baylor College of Medicine
Objective:

We describe two cases of persistent CMV positivity in resected brain tissue of patients with congenital CMV despite resolution of viremia

Background:

Cytomegalovirus is the most common congenital viral infection, with 30,000 affected infants born in the United States annually and is the leading non-genetic cause of hearing loss and developmental delay. Patients classically present with hepatosplenomegaly, thrombocytopenia, petechiae, and jaundice as well as a range of neurological symptoms such as hearing loss, vision loss, developmental delay, epilepsy, microcephaly, and brain malformations. However, many patients present with neurologic symptoms either in isolation or out of proportion to systemic findings.

Design/Methods:

Not applicable.

Results:

We describe the cases of two female patients with congenital CMV. As neonates one was asymptomatic and the other had only a mild petechial rash. However, within the first year of life they were noted to have sensorineural hearing loss, developmental delay, and structural brain anomalies including polymicrogyria and microcephaly. One was diagnosed with congenital CMV by retrospective testing of the dried blood spot from her newborn screen and the other via urine culture at 32 days. Serum CMV PCR was negative in the first patient. The second was initially positive and dropped to undetectable levels by 9 months.  Both developed medically refractory focal seizures requiring hemispherectomy. Interestingly CMV PCR of resected brain tissue was positive in each patient despite negative serum tests suggesting the presence of viral persistence in brain tissue.  

Conclusions:

These cases highlight the potential for different mechanisms and disease trajectories in CNS and peripheral tissues in congenital CMV. Whether detection of CMV DNA in brain tissue from these patients represents ongoing active infection or latent viral infection is not known. Further research into cases such as these may provide insight into divergent severities between CNS and peripheral manifestations seen in patients with congenital CMV.

10.1212/WNL.0000000000203909